 Connection
John Mitchell to Esophageal Neoplasms
This is a "connection" page, showing publications John Mitchell has written about Esophageal Neoplasms.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.589 |
|
|
|
-
Mitchell JD, Krasna MJ. The society of thoracic surgeons esophageal cancer guideline series. Ann Thorac Surg. 2013 Jul; 96(1):7.
Score: 0.290
-
Stuart CM, Mott NM, Bronsert MR, Franco SR, Gleisner AL, Mungo B, McCarter MD, Randhawa SK, David EA, Mitchell JD, Meguid RA. Ongoing Implications of the COVID-19 Pandemic Environment on Esophageal Cancer Characteristics and Treatment in the United States. J Surg Oncol. 2025 Aug; 132(2):267-276.
Score: 0.167
-
Schefter TE, Patel M, McCarter M, Kane M, Russ PD, Nash SR, Shah RJ, Mitchell JD. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, Part 2. Oncology (Williston Park). 2005 Jun; 19(7):830, 835-6, 838 passim.
Score: 0.166
-
Schefter TE, Patel M, McCarter M, Kane M, Russ PD, Nash SR, Shah RJ, Mitchell JD. Triple-modality therapy for a woman with locally advanced thoracic esophageal adenocarcinoma, part 1. Oncology (Williston Park). 2005 May; 19(6):775-8, 783-4, 788 passim.
Score: 0.165
-
Yee EJ, Read J, Ziogas IA, Stuart CM, Olsen J, Kim SS, Mitchell JD, Meguid RA, McCarter MD, Mungo B. More May Not Be Better: Comparison of Oncologic Outcomes Following Induction Chemotherapy Plus Chemoradiation and Chemoradiation Alone for Esophageal Adenocarcinoma. J Surg Oncol. 2025 Mar; 131(4):598-606.
Score: 0.160
-
Stuart CM, Mott NM, Dyas AR, Byers S, Gergen AK, Mungo B, Stewart CL, McCarter MD, Randhawa SK, David EA, Mitchell JD, Meguid RA. The Effect of Laparoscopic Gastric Ischemic Preconditioning Prior to Esophagectomy on Anastomotic Stricture Rate and Comparison with Esophagectomy-Alone Controls. Ann Surg Oncol. 2024 Jul; 31(7):4261-4270.
Score: 0.152
-
Stuart CM, Meguid RA, Bronsert MR, Rodriguez Franco S, Mungo B, Schulick RD, Gleisner AL, McCarter MD, Mitchell JD, Dyas AR. The United States experience with diagnosing and treating esophageal cancer during the SARS-CoV-2 pandemic: A retrospective cohort study. Int J Cancer. 2024 04 01; 154(7):1204-1220.
Score: 0.150
-
Dyas AR, Mungo B, Bronsert MR, Stuart CM, Mungo AH, Mitchell JD, Randhawa SK, David E, Stewart CL, McCarter MD, Meguid RA. National trends in technique use for esophagectomy: Does primary surgeon specialty matter? Surgery. 2024 02; 175(2):353-359.
Score: 0.150
-
Stuart CM, Gergen AK, Byers S, Vigneshwar N, Madsen H, Johnson J, Oase K, Garduno N, Marsh M, Pratap A, Mitchell JD, David EA, Randhawa SK, Meguid RA, McCarter MD, Stewart CL. ASO Author Reflections: Gastric Ischemic Preconditioning Prior to Esophagectomy: Laparoscopic Gastric Ischemic Preconditioning. Ann Surg Oncol. 2023 09; 30(9):5826-5827.
Score: 0.145
-
Gergen AK, Stuart CM, Byers S, Vigneshwar N, Madsen H, Johnson J, Oase K, Garduno N, Marsh M, Pratap A, Mitchell JD, David EA, Randhawa S, Meguid RA, McCarter MD, Stewart CL. Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison with Historical Controls. Ann Surg Oncol. 2023 Sep; 30(9):5815-5825.
Score: 0.145
-
Stuart CM, Dyas AR, Byers S, Velopulos C, Randhawa S, David EA, Pritap A, Stewart CL, Mitchell JD, McCarter MD, Meguid RA. Social vulnerability is associated with increased postoperative morbidity following esophagectomy. J Thorac Cardiovasc Surg. 2023 10; 166(4):1254-1261.
Score: 0.144
-
Worrell SG, Alvarado CE, Thibault D, Towe CW, Mitchell JD, Vekstein A, Kosinski AS, Hartwig MG, Linden PA. Impact of Diabetes on Pathologic Response to Multimodality Therapy for Esophageal Cancer. Ann Thorac Surg. 2024 01; 117(1):190-196.
Score: 0.137
-
Ho F, Torphy RJ, Friedman C, Leong S, Kim S, Wani S, Schefter T, Scott CD, Mitchell JD, Weyant MJ, Meguid RA, Gleisner AL, Goodman KA, McCarter MD. Induction Chemotherapy Plus Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Junction Adenocarcinoma. Ann Surg Oncol. 2021 Nov; 28(12):7208-7218.
Score: 0.125
-
Gergen AK, Halpern AL, Helmkamp L, Torphy RJ, White AM, Mitchell JD, Meguid RA, Scott CD, Gleisner AL, McCarter MD, Weyant MJ. Outcomes After Converted Minimally Invasive to Open Esophagectomy in Patients With Esophageal Cancer. Ann Thorac Surg. 2021 11; 112(5):1593-1599.
Score: 0.122
-
Bhagat R, Bronsert MR, Juarez-Colunga E, Weyant MJ, Mitchell JD, Glebova NO, Henderson WG, Fullerton D, Meguid RA. Postoperative Complications Drive Unplanned Readmissions After Esophagectomy for Cancer. Ann Thorac Surg. 2018 05; 105(5):1476-1482.
Score: 0.100
-
Stewart CL, Wilson L, Hamm A, Bartsch C, Boniface M, Gleisner A, Mitchell JD, Weyant MJ, Meguid R, Gajdos C, Edil BH, McCarter M. Is Chemical Pyloroplasty Necessary for Minimally Invasive Esophagectomy? Ann Surg Oncol. 2017 May; 24(5):1414-1418.
Score: 0.093
-
Little AG, Lerut AE, Harpole DH, Hofstetter WL, Mitchell JD, Altorki NK, Krasna MJ. The Society of Thoracic Surgeons practice guidelines on the role of multimodality treatment for cancer of the esophagus and gastroesophageal junction. Ann Thorac Surg. 2014 Nov; 98(5):1880-5.
Score: 0.079
-
Varghese TK, Hofstetter WL, Rizk NP, Low DE, Darling GE, Watson TJ, Mitchell JD, Krasna MJ. The society of thoracic surgeons guidelines on the diagnosis and staging of patients with esophageal cancer. Ann Thorac Surg. 2013 Jul; 96(1):346-56.
Score: 0.072
-
Halpern AL, Friedman C, Torphy RJ, Al-Musawi MH, Mitchell JD, Scott CD, Meguid RA, McCarter MD, Weyant MJ, Gleisner AL. Conversion to open surgery during minimally invasive esophagectomy portends worse short-term outcomes: an analysis of the National Cancer Database. Surg Endosc. 2020 08; 34(8):3470-3478.
Score: 0.028
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|